Solta Medical, Inc. (SLTM)

[mlkrborn]

Solta Medical beats by $0.04, beats on revs; guides FY12 revs in-line (SLTM) : Reports Q2 (Jun) earnings of $0.04 per share, $0.04 better than the Capital IQ Consensus Estimate of ($0.00); revenues rose 29.1% year/year to $37.3 mln vs the $36.09 mln consensus. Co raises guidance for FY12, sees FY12 revs of $142-144 mln up from $140-143 mln vs. $144.12 mln Capital IQ Consensus Estimate. Non-GAAP gross margin is now estimated to be in the range of 64% to 67% for the full year 2012 as compared to the Company's previously issued range of 63% to 66%. Non-GAAP gross margin excludes non-cash amortization charges, non-cash stock based compensation charges, severance costs, and acquisition related adjustments. Non-GAAP gross margin for the six months ended June 30, 2012 was 67.5%. The outlook for positive non-GAAP EBITDA for every quarter and for the full-year 2012 remains unchanged. Non-GAAP EBITDA excludes non-cash amortization charges, non-cash stock based compensation charges, severance costs, and acquisition related adjustments. Non-GAAP EBITDA for the six months ended June 30, 2012 was $4.7 million.